-
Publication Venue For
-
Professional Practice Committee: Standards of Medical Care in Diabetes—2020.
43:S3-S3.
2020
-
Professional Practice Committee: Standards of Medical Care in Diabetes—2019.
42:S3-S3.
2019
-
Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial..
dc170885.
2017
-
Pancreatic Safety of Sitagliptin in the TECOS Study..
40:164-170.
2017
-
Diabetes care: Lagniappe and seeing is believing!.
39:1069-1071.
2016
-
Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions.
39:323-329.
2016
-
Could the discrepancy in perceived emotional care received and provided be a barrier to active diabetes selfmanagement? Insights from the second diabetes attitudes, wishes and needs (DAWN2) study.
39:e20-e21.
2016
-
Patient-reported outcomes and continuous glucose monitoring: Can we do better with artificial pancreas devices?.
38:e70.
2015
-
Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes.
35:2198-2200.
2012
-
Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010 (Diabetes Care (2012) 35, (434-445)).
35:1395.
2012
-
Response to comment on: Wheeler et al. Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010. Diabetes Care 2012;35:434-445.
35.
2012
-
Glycemic thresholds for diabetes-specific retinopathy: Implications for diagnostic criteria for diabetes (Diabetes Care (2011) 34, (145-150)).
34:1888.
2011
-
The association between maternal glucose concentration and child BMI at age 3 years..
34:480-484.
2011
-
Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis..
32:2307-2313.
2009
-
Erratum: Diabetic retinopathy and the risk of coronary heart disease: The Atherosclerosis Risk in Communities Study (Diabetes Care (2007) 30, (1742-1746)).
30:2762.
2007
-
Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach..
30:395-402.
2007
-
Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes..
30:43-48.
2007
-
High-risk individuals' willingness to pay for diabetes risk-reduction programs..
29:1351-1356.
2006
-
Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab..
29:1114-1116.
2006
-
Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression..
29:265-270.
2006
-
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes..
29:9-14.
2006
-
Risking health to avoid injections: preferences of Canadians with type 2 diabetes..
28:2243-2245.
2005
-
Early pregnancy insulin resistance and subsequent gestational diabetes mellitus..
28:1207-1208.
2005
-
Effectiveness of diabetic therapeutic footwear in preventing reulceration: response to Maciejewski et al..
27:3024-3025.
2004
-
Caffeine impairs glucose metabolism in type 2 diabetes..
27:2047-2048.
2004
-
Effectiveness of diabetic therapeutic footwear in preventing reulceration..
27:1774-1782.
2004
-
Diabetes-related utilization and costs for inpatient and outpatient services in the Veterans Administration..
27 Suppl 2:B69-B73.
2004
-
The effect of the PREMIER interventions on insulin sensitivity..
27:340-347.
2004
-
Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus..
27:21-27.
2004
-
Screening for celiac disease in children with type 1 diabetes: two views of the controversy..
26:1932-1939.
2003
-
Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans..
26:791-798.
2003
-
First-trimester C-reactive protein and subsequent gestational diabetes..
26:819-824.
2003
-
Prevalence and costs of major depression among elderly claimants with diabetes..
26:415-420.
2003
-
Quality of care for patients diagnosed with diabetes at screening..
26:367-371.
2003
-
Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III..
26:468-470.
2003
-
Weight control practices and disordered eating behaviors among adolescent females and males with type 1 diabetes: associations with sociodemographics, weight concerns, familial factors, and metabolic outcomes..
25:1289-1296.
2002
-
Impact of diabetes screening on quality of life..
25:1022-1026.
2002
-
Hostility, race, and glucose metabolism in nondiabetic individuals..
25:835-839.
2002
-
Stress management improves long-term glycemic control in type 2 diabetes..
25:30-34.
2002
-
Rate and predictors of glycemic testing of nondiabetic patients in a managed care population..
24:957-959.
2001
-
Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity..
24:117-123.
2001
-
Glycemic control and impaired autonomic function: Is glucose the sole culprit? [11].
23:1863-1864.
2000
-
Personality correlates of glycemic control in type 2 diabetes..
23:1321-1325.
2000
-
Is there a glycemic threshold for impaired autonomic control?.
23:826-830.
2000
-
The family and disease management in Hispanic and European-American patients with type 2 diabetes..
23:267-272.
2000
-
Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes..
21:2050-2055.
1998
-
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study..
21:949-958.
1998
-
Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population..
21:959-966.
1998
-
Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points..
21:655-657.
1998
-
Physical activity and NIDDM in African-Americans. The Pitt County Study..
21:555-562.
1998
-
Increased hydrogen peroxide formation in polymorphonuclear leukocytes of IDDM patients..
21:326-327.
1998
-
Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes..
20:1539-1542.
1997
-
Solitary pancreas transplantation. Experience with 62 consecutive cases..
20:362-368.
1997
-
Major depressive disorder in youths with IDDM. A controlled prospective study of course and outcome..
20:45-51.
1997
-
Psychiatric disorders in youths with IDDM: rates and risk factors..
20:36-44.
1997
-
Clinical and radiographic findings that lead to intervention in diabetic patients with foot ulcers. A nationwide survey of primary care physicians..
19:755-757.
1996
-
Lipoprotein(a) and silent myocardial ischemia in IDDM..
17:1365-1367.
1994
-
A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors..
17:840-846.
1994
-
Relaxation training for NIDDM. Predicting who may benefit..
16:1087-1094.
1993
-
Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association..
15:1673.
1992
-
Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association..
15:1668-1672.
1992
-
Stress and diabetes mellitus..
15:1413-1422.
1992
-
Microangiopathic ischemic myopathy of semimembranosus muscle in patient with diabetes mellitus..
15:586-587.
1992
-
Plasma levels of beta-endorphin and adrenocorticotropic hormone in IDDM and NIDDM..
15:590-591.
1992
-
Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing..
13:1044-1050.
1990
-
Family functioning and metabolic control of school-aged children with IDDM..
12:409-414.
1989
-
Accuracy of nurses in performing capillary blood glucose monitoring..
12:298-301.
1989
-
Prevalence of asymptomatic bacteriuria in subjects with NIDDM in San Luis Valley of Colorado..
11:708-712.
1988
-
Type A behavior pattern and chronic glycemic control in individuals with IDDM..
11:361-362.
1988
-
Psychological predictors of glucose control in patients with IDDM..
11:798-800.
1988
-
Stress and autonomic nervous system in type II diabetes. A hypothesis..
11:83-85.
1988
-
Relaxation Therapy: A Reply.
10:794-795.
1987
-
Cognitive Functioning and Diabetes: A Reply.
10:136-137.
1987
-
Effects of relaxation therapy on patients with type I diabetes mellitus..
10:72-75.
1987
-
Differential glycemic response to stress in type A and type B individuals with IDDM..
9:550-552.
1986
-
Relaxation-induced improvement in glucose tolerance is associated with decreased plasma cortisol..
7:203-204.
1984
-
Accuracy of two systems for blood glucose monitoring without a meter (Chemstrip/Visidex)..
6:533-535.
1983
-
The effects of relaxations on glucose tolerance in non-insulin-dependent diabetes..
6:176-179.
1983
-
Induced basal normoglycemia and altered platelet aggregation in non-insulin-dependent diabetes..
5:433-437.
1982
-
The role of behavior in diabetes care..
5:337-342.
1982
-
An algebra for adiposity?.
4:328-329.
1981
-
For Reading on Writing.
3:198-198.
1980
-
Cheiralgia paresthetica in diabetes mellitus..
1:365-366.
1978
-
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.
2022